References
- 1. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARSCoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar; 19(3):141-54. DOI: 10.1038/s41579-020-00459-710.1038/s41579-020-00459-7
- 2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA 2020;323:1239-42. DOI: 10.1001/ jama.2020.264810.1001/jama.2020.2648
- 3. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-4. DOI: 10.1016/S0140-6736(20)30628-010.1016/S0140-6736(20)30628-0
- 4. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010;38:S26-34. DOI: 10.1097/CCM. 0b013e3181c98d2110.1097/CCM.0b013e3181c98d21
- 5. Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021 Mar;46:100745. DOI: 10.1016/j.blre.2020.10074510.1016/j.blre.2020.100745
- 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI: 10.1016/S0140-6736(20)30566-310.1016/S0140-6736(20)30566-3
- 7. Teuwen L, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nature Rev Immunol. 2020;20:389-91. DOI: 10.1038/s41577-020-0343-010.1038/s41577-020-0343-0724024432439870
- 8. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324-9. DOI: 10.1111/jth.1485910.1111/jth.14859726473032306492
- 9. Lee SG, Fralick M, Sholzberg M. Coagulopathy associated with COVID-19. CMAJ. 2020 May 25;192(21):E583. DOI: 10.1503/cmaj.20068510.1503/cmaj.200685725997032357997
- 10. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 Jun 4;135(23):2033-40. DOI: 10.1182/blood.202000600010.1182/blood.2020006000727382732339221
- 11. Levi M, van der Poll T, Schultz M. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol. 2012 Jan;34(1):167-79. DOI: 10.1007/s00281-011-0283-710.1007/s00281-011-0283-7323366021805225
- 12. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Hae-most. 1996 Nov;76(5):738-42. DOI: 10.1055/s-0038-165065310.1055/s-0038-1650653
- 13. Stirling D, Hannant WA, Ludlam CA. Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6. Thromb Haemost 1998;79:74-8. DOI: 10.1055/s-0037-161422310.1055/s-0037-1614223
- 14. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol. 2001 Oct;115(1):3-1. DOI: 10.1046/j.1365-2141.2001.03061.x10.1046/j.1365-2141.2001.03061.x11722403
- 15. Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020 Jun;46(6):1105-8. DOI: 10.1007/s00134-020-06059-610.1007/s00134-020-06059-6718653532347323
- 16. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-9. DOI: 10.1001/jama.2020.158510.1001/jama.2020.1585704288132031570
- 17. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020 May 20;18(1):206. DOI: 10.1186/ s12967-020-02374-010.1186/s12967-020-02374-0723788032434518
- 18. Muniyappa R, Gubbi S. COVID-19 pandemic, corona-viruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020;318:E736-E741. DOI: 10.1152/ajpendo.00124.202010.1152/ajpendo.00124.2020719163332228322
- 19. Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020 Sep 18;11(1):53. DOI: 10.1186/ s13293-020-00330-710.1186/s13293-020-00330-7749899732948238
- 20. Wong RS, Wu A, To KF, Lee N, Lam CWK, Wong CK, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003; 326: 1358-62. DOI: 10.1136/ bmj.326.7403.135810.1136/bmj.326.7403.135816212412816821
- 21. Panesar, NS. What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med Hypotheses 2008; 71: 298-301. DOI: 10.1016/j.mehy.2008.03.01910.1016/j.mehy.2008.03.019713135218448259
- 22. Yang M, Li CK, Li K, Hon KL, Ng MH, Chan PK, et al. Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med 2004;14:311-5. DOI: 10.3892/ijmm.14.2.31110.3892/ijmm.14.2.311